- Home
- OPK
OPK
OPKO Health Inc.
as of 12-03-2025 3:58pm EST
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | MIAMI |
| Market Cap: | 998.0M | IPO Year: | 1995 |
| Target Price: | $2.28 | AVG Volume (30 days): | 2.8M |
| Analyst Decision: | Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.25 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.11 - $2.04 | Next Earning Date: | 10-29-2025 |
| Revenue: | $642,067,000 | Revenue Growth: | -9.75% |
| Revenue Growth (this year): | -15.22% | Revenue Growth (next year): | -4.81% |
AI-Powered OPK Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of OPKO Health Inc. (OPK)
CEO & Chairman
Avg Cost/Share
$1.32
Shares
580,000
Total Value
$768,807.41
Owned After
216,513,578
CEO & Chairman
Avg Cost/Share
$1.34
Shares
580,000
Total Value
$771,327.70
Owned After
216,513,578
CEO & Chairman
Avg Cost/Share
$1.30
Shares
580,000
Total Value
$759,115.40
Owned After
216,513,578
CEO & Chairman
Avg Cost/Share
$1.27
Shares
533,300
Total Value
$678,905.83
Owned After
216,513,578
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 21, 2025 | Buy | $1.32 | 580,000 | $768,807.41 | 216,513,578 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 20, 2025 | Buy | $1.34 | 580,000 | $771,327.70 | 216,513,578 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 19, 2025 | Buy | $1.30 | 580,000 | $759,115.40 | 216,513,578 | |
| FROST PHILLIP MD ET AL | OPK | CEO & Chairman | Nov 18, 2025 | Buy | $1.27 | 533,300 | $678,905.83 | 216,513,578 |
Compare OPK vs Leading Stocks
See how OPK stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "OPK OPKO Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.